Insider Transactions in Q3 2024 at Longeveron Inc. (LGVN)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2024
|
Neil E Hare |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+44.46%
|
-
|
|
Aug 15
2024
|
Rock Soffer |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+9.2%
|
-
|
|
Aug 15
2024
|
Ursula Ungaro |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+49.47%
|
-
|
|
Aug 15
2024
|
Khoso Baluch |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+37.98%
|
-
|
|
Aug 15
2024
|
Joshua Hare Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,766
+11.42%
|
-
|
|
Aug 15
2024
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
31,505
-9.84%
|
$63,010
$2.46 P/Share
|
|
Aug 15
2024
|
Paul T Lehr General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
178,133
+35.74%
|
-
|
|
Aug 15
2024
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,248
-30.28%
|
$78,496
$2.46 P/Share
|
|
Aug 15
2024
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
311,250
+48.47%
|
-
|
|
Aug 15
2024
|
Lisa Locklear Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,035
-7.9%
|
$28,070
$2.46 P/Share
|
|
Aug 15
2024
|
Lisa Locklear Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
174,750
+49.59%
|
-
|
|
Aug 15
2024
|
Nataliya Agafonova Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,391
-8.11%
|
$28,782
$2.46 P/Share
|
|
Aug 15
2024
|
Nataliya Agafonova Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,750
+49.75%
|
-
|
|
Jul 02
2024
|
Neha J. Motwani |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
$16,000
$1.68 P/Share
|
|
Jul 02
2024
|
Roger Joseph Hajjar |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
$16,000
$1.68 P/Share
|
|
Jul 01
2024
|
Lisa Locklear Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-10.91%
|
$357
$1.57 P/Share
|